Skip to main content
  • Paul Scherrer Institut PSI
  • PSI Research, Labs & User Services

Digital User Office

  • Digital User Office
  • DE
  • EN
  • FR
Paul Scherrer Institut (PSI)
Search
Paul Scherrer Institut (PSI)

Hauptnavigation

  • Research at PSIOpen mainmenu item
    • Research Initiatives
    • Ethics and Research integrity
    • Scientific Highlights
    • Scientific Events
    • Scientific Career
    • PSI-FELLOW
    • PSI Data Policy
  • Research Divisions and LabsOpen mainmenu item
    • Overview
    • Research with Neutrons and Muons
    • Photon Science
    • Energy and Environment
    • Nuclear Energy and Safety
    • Biology and Chemistry
    • Scientific Computing, Theory and Data
    • Large Research Facilities
  • Facilities and InstrumentsOpen mainmenu item
    • Overview
    • Large Research Facilities
    • Facilities
    • PSI Facility Newsletter
  • PSI User ServicesOpen mainmenu item
    • User Office
    • Methods at the PSI User Facilities
    • Proposals for beam time
    • Proposal Deadlines
    • Data Analysis Service (PSD)
    • EU support programmes
  • New ProjectsOpen mainmenu item
    • SLS 2.0
    • IMPACT
  • DE
  • EN
  • FR

Digital User Office (mobile)

  • Digital User Office

You are here:

  1. PSI Home
  2. Labs & User Services
  3. BIO
  4. CRS
  5. Facilities and Instruments

Secondary navigation

Center for Radiopharmaceutical Sciences (CRS)

  • Laboratory Head
  • Project Leader
  • Scientific Highlights
  • Groups
    • Nuclide Chemistry
    • Pharmacology
    • Clinical Drug Supply
    • Radionuclide-Production and Maintenance
    • Radionuclide Development
  • Facilities and Instruments
  • Teaching and Education
  • Publications
  • Team / Contact
  • News & Events

Facilities and Instruments

Facilities at the Center for Radiopharmaceutical Sciences (CRS)

GMP Facility

In the CRS there is a state-of-art GMP facility for the production of radiopharmaceuticals under good manufacturing practice (GMP) for clinical applications.

For more information, please follow this link or contact Susanne Geistlich.

PET/SPECT/CT 

The CRS has a preclinical nuclear imaging facility in house. Both, single photon emission computed tomography (SPECT), and positron emission tomography (PET) with an anatomic imaging modality by computed tomography (CT). These instrumentations give us the ability to analyze and visualize biologically significant events (such as tumor growth, hypoxia, angiogenesis, apoptosis) in combination with the anatomical information provided by CT.

For more information, please contact Dr. Martin Béhé.

LC/ESI-TOF-MS

The sensitivity and resolution of liquid chromatography/electrospray ionization time-of-flight mass spectrometry (LCT Premier Mass Spectrometer, Waters AG) allows the determining of mass of peptides or proteins.

For more information, please contact Alain Blanc.

Sidebar

Contact

Prof. Dr. Roger Schibli
Center for Radiopharmaceutical Sciences
Paul Scherrer Institut
OIPA/103
5232 Villigen PSI
Switzerland

Telephone Office: +41 56 310 28 43
E-mail Office: sandha.keller@psi.ch

Contact

ETH
Prof. Dr. Roger Schibli
Swiss Federal Institute of Technology Zurich
Radiopharmaceutical Sciences
ETH Zurich

Contact

University Hospital Zurich
Radiopharmacy
USZ

Directions to PSI

How to get to the Paul Scherrer Institute (description and map)

top

Footer

Paul Scherrer Institut

Forschungsstrasse 111
5232 Villigen PSI
Switzerland

Telephone: +41 56 310 21 11
Telefax: +41 56 310 21 99

How to find us
Contact

Visitor Centre psi forum
School Lab iLab (in German)
Center for Proton Therapy
PSI Education Centre
PSI Guest House
PSI Gastronomie (in German)
psi forum shop

Service & Support

  • Phone Book
  • User Office
  • Accelerator Status
  • PSI Publications
  • Suppliers
  • E-Billing
  • Computing
  • Safety (in German)

Career

  • Working at PSI
  • Job Opportunities
  • Training and further education
  • Career Center
  • Vocational Training (in German)
  • PSI Education Center

For the media

  • PSI in brief
  • Facts and Figures
  • Media corner
  • Media Releases
  • Social Media

Follow us: Twitter (in English) LinkedIn Youtube Facebook Instagram Issuu RSS

Footer legal

  • Imprint
  • Terms and Conditions
  • Editors' login